申请人:American Home Products Corporation
公开号:US05468760A1
公开(公告)日:1995-11-21
This invention relates to compounds compounds useful in treating diseases mediated by one or more leukotrienes or oxidative modification of low density lipoprotein such as inflammation, bronchoconstriction or atherosclerosis. The compounds of this invention have the formula: ##STR1## wherein R.sup.1 and R.sup.3 are independently hydrogen, fluorine, chlorine, bromine, iodine, C.sub.1 -C.sub.6 alkyl, trifluoromethyl, C.sub.1 -C.sub.6 alkoxy, or C.sub.1 -C.sub.6 trifluoroalkoxy; R.sup.2 and R.sup.4 are hydrogen or methyl independently; R.sup.5 is hydrogen, methyl or hydroxy; X and Z are independently oxygen or sulfur; and Y is --CH.sub.2 --, --CH(CH.sub.3)--, or --CH.dbd.CHCH(CH.sub.3)--.
这项发明涉及用于治疗由一个或多个白三烯或低密度脂蛋白的氧化修饰介导的疾病,如炎症、支气管痉挛或动脉粥样硬化的化合物。本发明的化合物具有以下结构式:##STR1##其中R.sup.1和R.sup.3分别独立地是氢、氟、氯、溴、碘、C.sub.1 -C.sub.6烷基、三氟甲基、C.sub.1 -C.sub.6烷氧基或C.sub.1 -C.sub.6三氟烷氧基;R.sup.2和R.sup.4分别是氢或甲基;R.sup.5是氢、甲基或羟基;X和Z独立地是氧或硫;Y是--CH.sub.2 --、--CH(CH.sub.3)--或--CH.dbd.CHCH(CH.sub.3)--。